Benitec Biopharma Inc. (BNTC)
NASDAQ: BNTC · Real-Time Price · USD
12.43
-0.57 (-4.38%)
Jun 26, 2026, 3:36 PM EDT - Market open
Benitec Biopharma Market Cap
Benitec Biopharma has a market cap or net worth of $427.02 million as of June 26, 2026. Its market cap has decreased by -1.77% in one year.
Market Cap
427.02M
Enterprise Value
248.64M
1-Year Change
-1.77%
Ranking
Category
Stock Price
$12.43
Market Cap Chart
Since June 26, 2014, Benitec Biopharma's market cap has decreased from $2.23B to $427.02M, a decrease of -80.82%. That is a compound annual growth rate of -12.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2026 | 427.02M | -6.38% |
| Dec 31, 2025 | 456.12M | 55.56% |
| Dec 31, 2024 | 293.22M | 3,429.00% |
| Dec 29, 2023 | 8.31M | 74.68% |
| Dec 30, 2022 | 4.76M | -77.78% |
| Dec 31, 2021 | 21.41M | 61.99% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Contineum Therapeutics | 445.27M |
| Forte Biosciences | 443.51M |
| Autolus Therapeutics | 441.80M |
| vTv Therapeutics | 438.37M |
| Sagimet Biosciences | 435.97M |
| Century Therapeutics | 434.66M |
| Prelude Therapeutics | 434.40M |
| Ovid Therapeutics | 433.01M |